Xilio Therapeutics Stock (NASDAQ: XLO) stock price, news, charts, stock research, profile.
You can purchase shares of Xilio Therapeutics (NASDAQ:XLO) through any online brokerage.
Other companies in Xilio Therapeutics’s space includes: Serina Therapeutics (AMEX:SER), Fortress Biotech (NASDAQ:FBIO), Kezar Life Sciences (NASDAQ:KZR), Galectin Therapeutics (NASDAQ:GALT) and Estrella Immunopharma (NASDAQ:ESLA).
Xilio Therapeutics has a consensus price target of $14.25.
The stock price for Xilio Therapeutics (NASDAQ: XLO) is $1.07 last updated December 24, 2024 at 4:48 PM EST.
There are no upcoming dividends for Xilio Therapeutics.
Xilio Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Xilio Therapeutics.
Xilio Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.